ArticleBMJ open2025

Effectiveness of an AI-enhanced management system for coronary heart disease (AIM-CHD): rationale and design of a single-centre, open-label, randomised, parallel-controlled trial.

Zhengqing Ba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.